Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapyBoaz Wong, Jean‐Simon Diallo|Molecular Therapy|2023Cited by 23